Want to join the conversation?
$AKRX received a notice from Nasdaq listing qualifications staff stating the company is not in compliance with a Nasdaq listing rule, as it failed to submit its Form 10-Q for quarter ended Sept. 30, with the SEC by Nov. 9, 2015. Nasdaq panel has the discretion to grant an extension, $AKRX said.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?